CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishibe, N.
Right arrow Articles by Kelsey, K. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishibe, N.
Right arrow Articles by Kelsey, K. T.

Cancer Epidemiology Biomarkers & Prevention, Vol 6, Issue 12 1075-1080, Copyright © 1997 by American Association for Cancer Research


ARTICLES

Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans

N Ishibe, JK Wiencke, ZF Zuo, A McMillan, M Spitz and KT Kelsey
Department of Epidemiology, Harvard School of Public Health, Boston Massachusetts 02115, USA.

The gene-environment associations between potential carcinogenic agents modified by polymorphisms in the cytochrome P450 1A1 (CYP1A1) gene and lung cancer risk were assessed in a hospital-based case-control study composed of African- and Mexican-Americans. The study involved 171 cases and 295 controls identified from the greater Houston and San Antonio metropolitan areas. Both the exon 7 and MspI polymorphisms were analyzed by RFLP of PCR-amplified DNA, and in addition, the African-American-specific polymorphism was assayed for subjects who reported that they were African-American. Logistic regression analysis was performed to assess the association between each of the CYP1A1 polymorphisms and lung cancer, adjusting for the matching variables (age, sex, ethnicity) and other potential risk factors. Interactions between pack-years smoked, CYP1A1 genotypes, and case status were also evaluated. The variant allele frequencies did not differ by case status, but the distributions of genotypes were strikingly different by ethnicity. In addition, both the exon 7 and MspI polymorphisms, but not the African-American-specific polymorphism, were modified by the amount of cigarette consumption measured in pack-years. An approximate 2-fold increase in lung cancer risk among individuals with one or more of the variant alleles was observed among light smokers (defined as having smoked < or = 30 pack-years). The respective risk ratios for the exon 7 and MspI polymorphisms were 2.26 (95% confidence interval, 0.82-6.26) and 2.03 (95% confidence interval, 1.03-4.01) at low smoking dose. No such increase in risk was found among heavy smokers (> 30 pack-years). This phenomenon at low smoking dose was also observed when the two common polymorphisms were combined, which resulted in was a progressive increase in risk with an increasing number of variant alleles. These results indicate that at low smoking levels, the MspI and exon 7 CYP1A1 genetic polymorphisms confer susceptibility to lung cancer.


This article has been cited by other articles:


Home page
Occup. Environ. Med.Home page
X Qin, Y Wu, W Wang, T Liu, L Wang, Y Hu, and D Chen
Low organic solvent exposure and combined maternal-infant gene polymorphisms affect gestational age
Occup. Environ. Med., July 1, 2008; 65(7): 482 - 487.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A.S. Wenzlaff, M.L. Cote, C.H. Bock, S.J. Land, S.K. Santer, D.R. Schwartz, and A.G. Schwartz
CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study
Carcinogenesis, December 1, 2005; 26(12): 2207 - 2212.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. F. Masson, L. Sharp, S. C. Cotton, and J. Little
Cytochrome P-450 1A1 Gene Polymorphisms and Risk of Breast Cancer: A HuGE Review
Am. J. Epidemiol., May 15, 2005; 161(10): 901 - 915.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Georgiadis, J. Topinka, D. Vlachodimitropoulos, M. Stoikidou, M. Gioka, G. Stephanou, H. Autrup, N. A. Demopoulos, K. Katsouyanni, R. Sram, et al.
Interactions between CYP1A1 polymorphisms and exposure to environmental tobacco smoke in the modulation of lymphocyte bulky DNA adducts and chromosomal aberrations
Carcinogenesis, January 1, 2005; 26(1): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. L. Slattery, W. Samowtiz, K. Ma, M. Murtaugh, C. Sweeney, T. R. Levin, and S. Neuhausen
CYP1A1, Cigarette Smoking, and Colon and Rectal Cancer
Am. J. Epidemiol., November 1, 2004; 160(9): 842 - 852.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. G. Shields
Tobacco Smoking, Harm Reduction, and Biomarkers
J Natl Cancer Inst, October 2, 2002; 94(19): 1435 - 1444.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
X. Wang, B. Zuckerman, C. Pearson, G. Kaufman, C. Chen, G. Wang, T. Niu, P. H. Wise, H. Bauchner, and X. Xu
Maternal Cigarette Smoking, Metabolic Gene Polymorphism, and Infant Birth Weight
JAMA, January 9, 2002; 287(2): 195 - 202.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. B. J. Smith, P. A. Harper, J. M. Y. Wong, M. S. M. Lam, K. R. Reid, D. Petsikas, and T. E. Massey
Human Lung Microsomal Cytochrome P4501A1 (CYP1A1) Activities: Impact of Smoking Status and CYP1A1, Aryl Hydrocarbon Receptor, and Glutathione S-Transferase M1 Genetic Polymorphisms
Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 839 - 853.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. G. Shields and C. C. Harris
Cancer Risk and Low-Penetrance Susceptibility Genes in Gene-Environment Interactions
J. Clin. Oncol., June 11, 2000; 18(11): 2309 - 2315.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
F. P. Perera
Molecular Epidemiology: On the Path to Prevention?
J Natl Cancer Inst, April 19, 2000; 92(8): 602 - 612.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov
Genetic Polymorphism of CYP Genes, Alone or in Combination, as a Risk Modifier of Tobacco-related Cancers
Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 3 - 28.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.